Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
59.58
+0.31 (0.52%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Bio-Techne Stock Forecast
Stock Price Forecast
The 12 analysts that cover Bio-Techne stock have a consensus rating of "Buy" and an average price target of $70.58, which forecasts a 18.46% increase in the stock price over the next year. The lowest target is $59 and the highest is $90.
Price Target: $70.58 (+18.46%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bio-Techne stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 4 | 5 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 5 | 5 | 5 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $65 → $70 | Strong Buy | Maintains | $65 → $70 | +17.49% | Oct 14, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $60 → $72 | Buy | Maintains | $60 → $72 | +20.85% | Oct 7, 2025 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $61 → $73 | Hold → Buy | Upgrades | $61 → $73 | +22.52% | Sep 3, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $55 → $70 | Hold → Strong Buy | Upgrades | $55 → $70 | +17.49% | Aug 21, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $63 → $61 | Hold | Maintains | $63 → $61 | +2.38% | Aug 7, 2025 |
Financial Forecast
Revenue This Year
1.27B
from 1.22B
Increased by 3.97%
Revenue Next Year
1.37B
from 1.27B
Increased by 7.81%
EPS This Year
2.06
from 0.46
Increased by 347.18%
EPS Next Year
2.29
from 2.06
Increased by 11.41%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.3B | 1.5B | |||
| Avg | 1.3B | 1.4B | |||
| Low | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.1% | 18.0% | |||
| Avg | 4.0% | 7.8% | |||
| Low | -1.4% | -0.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.24 | 2.56 | |||
| Avg | 2.06 | 2.29 | |||
| Low | 1.87 | 1.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 386.2% | 24.5% | |||
| Avg | 347.2% | 11.4% | |||
| Low | 306.9% | -4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.